Five things to know:
1. Worldwide orthopedics sales in the fourth quarter were $2.2 billion; that’s a 1.6 percent decrease from the same time last year. In the U.S., orthopedics sales were down 3.5 percent with $1.3 billion.
2. Hip sales worldwide increased 2.1 percent year over year with quarterly revenue of $380 million. Knees saw $342 million in the fourth quarter, which is down 0.9 percent year over year.
3. Total fourth quarter sales were $24.8 billion, a 10.4 percent increase year over year. For the full year of 2021, Johnson & Johnson reported $93.8 billion in sales, a 13.6 percent increase compared to 2020.
4. The medical devices segment saw a 16.8 percent growth overall. This was largely driven by market recovery from COVID-19.
5. The company expects 2022 sales growth of 7.7 percent.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
